Abstract
Introduction
Despite the recent advances in diagnosis and treatment, mortality rates due to infective endocarditis (IE) remain high if not aggressively treated with antibiotics, whether or not associated with surgery. Data on the prevalence, epidemiology and etiology of IE from developing countries remain scarce. The aim of this observational, prospective cohort study was to report a 5-year experience of IE at two teaching hospitals in Rio de Janeiro, Brazil.
Material and methods
Demographical, anamnestic and microbiological characteristics of 71 IE patients were evaluated during the period of January 2009 to March 2013.
Results
The mean age of the IE patients was 49.8 ± 2.4 years, of which 41 (57.7 %) were males. The median time between the onset of symptoms and diagnosis of IE was 35.8 ± 4.8 days. A total of 31 (43.6 %) cases of community-acquired infective endocarditis (CAIE) and 40 (56.3 %) cases of healthcare-acquired infective endocarditis (HAIE) were observed. Staphylococcus aureus (30 %) was the predominant cause of IE. Streptococcus spp. (45.1 %) was the predominant cause of the CAIE while S. aureus (32.5 %) and Enterococcus spp. (27.2 %) were the main etiological agents of HAIE. For 64 (90.1 %) patients with native valve endocarditis, the mitral valve was the most commonly affected (48.3 %). The main source of IE in this cohort was intravascular catheter. The tricuspid valve and renal chronic insufficiency were more frequent in patients with HAIE than CAIE (p = 0.001). The risk factors associated with in-hospital mortality rate (46.4 %) in IE patients were: age over 45 (OR 3.4; 95 % CI 1.03–11.24; p = 0.04) and chronic renal insufficiency (OR 38.3; 95 % CI 3.2–449.4; p = 0.004).
Conclusions
At two main teaching hospitals in Brazil, Streptococcus spp. was the principal pathogen of CAIE while S. aureus and Enterococcus spp. were the most frequent causes of HAIE. IE remains a serious disease associated with high in-hospital mortality rate (46.6 %); especially, in individuals over 45 years of age and with renal failure. Data suggest that early surgery may improve the outcome of IE patients.
Similar content being viewed by others
References
Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276–86.
Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, Kharrat I, Jemaa MB, Hammemi A, Kammoun S. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:1247–51.
Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors an in-hospital outcome. Int J Infect Dis. 2010;14:e394–8.
Wu K, Lee SSJ, Tsai HC, Wann SR, Chen JK, Sy CL, Wang YH, Tseng YT, Chen YS. Non-nosocomial healthcare-associated infective endocarditis in Taiwan: an under recognized disease with poor outcome. BMC Infections. 2011;11:211–21.
Hirata R Jr, Pereira GA, Filardy AA, Gomes DL, Damasco PV, Rosa AC, Nagao PE, Pimenta FP, Mattos-Guaraldi AL. Potential pathogenic role of aggregative-adhering Corynebacterium diphtheriae of different clonal groups in endocarditis. Braz JMed Biol Res. 2008;41:986–91.
Begezsan II, Dorobat CM. Diagnostic approaches in infective endocarditis. Rev Med Chir Soc Med Nat Iasi. 2012;116:108–13.
Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965–75.
Nkomo VT. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart. 2007;93:1510–9.
Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J ClinMicrobiol Infect Dis. 2012;31:2905–10.
Damasco PV, Cavalcante FS, Chamon RC, Ferreira DC, Rioja SS, Potsch MV, Pastura MP, Marques VD, Castier MB, Marques EA, Santos KR. The first case report of non-nosocomial healthcare-associated infective endocarditis due to methicillin- resistant Staphylococcus aureus USA400 in Rio de Janeiro Brazil. Infection. 2013;41:851–4.
Tariq M, Alam M, Munir G, Khan MA, Smego RA Jr. Infective endocarditis: a five experience at tertiary care hospital in Pakistan. Int J Infect Dis. 2004;8:163–70.
Ruiz BM. Castillo Rivera AM, Navarro RC. Infectious endocarditis in intensive care medicine. Med Intensiva. 2012;36:457–9.
Lomas JM, Martinez-Marcos FJ, Placa A, Ivanova R, Gálvez J, Ruiz J, Reguera JM, Noureddine M, de la Torre J, de Alcarcón A. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect. 2010;16:1683–90.
Carroll KC, Weinstein MP. Manual and automated systems for detection and identification of microorganisms. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press; 2007. p. 192–217.
Mory F, Alauzet C, Matuszeswski C, Riegel P, Lozniewski A. Evaluation of the new vitek 2 anc card for identification of medically relevant anaerobic bacteria. J Clin Microbiol. 2009;47:1923–6.
Clinical and laboratory standards institute. performance for standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S-23. 2013.
Fernández-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A, Pahissa A. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis. 2008;47:1287–97.
Sucutu M, Davutoglu V, Ozer O, Aksoy M. Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia region. Arch Turk Soc Cardiol. 2010;38:107–11.
Ferreiros E, Nacinovich F, Casabé JH, Modenesi JC, Swieszkowski S, Corte C, Hernan CA, Kazelian L, Varini S. Epidemiologic, clinical and microbiologic profile of infective endocarditis in Argentina: a national survey. Am Heart J. 2006;151:545–52.
Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, ICE Investigators. Staphylococcus aureus endocarditis a consequence of medical progress. JAMA. 2005;293:3022–61.
Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, Sinha N. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol. 2005;98:253–60.
Yen HS, Murdoch DR. Global trends in infective endocarditis epidemiology. Curr Infect Dis Rep. 2012;14:367–72.
Hoen B, Duval X. Infective endocarditis. N Eng J Med. 2013;368:1425–33.
Sy RW, kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.
Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte, Chirouze C, Lung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alfa F, Duval X, Hoen. Preeminence of Staphylococcus aureus in infective endocarditis: a 1 year population based survey. Clin Infect Dis. 2012;54:1230–9.
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis prospective cohort study. Arch Intern Med. 2009;169:463–73.
Geiβdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, Schneider T. High frequency of Tropheryma whipplei in culture negative endocarditis. J Clin Microbiol. 2012;50:216–22.
Yiu KH, Siu CW, Lee KL, Fong YT, Chan HW, Lee SW, Lau CP, Tse HF. Emerging trends of community acquired infective endocarditis. Int J Cardiol. 2007;121:119–22.
Ramos JN, Santos LS, Vidal LMR, Pereira PMA, Salgado AA, Fortes CQ, Vieira VV, Mattos-Guaraldi AL, Hirata Jr R, Damasco PV. A case report and literature overview: Abiotrophia defectiva aortic valve endocarditis in developing countries. Infection 2014; [Epub ahead of print].
Acknowledgments
This work was supported by CAPES, FAPERJ, CNPq and SR-2/UERJ.
Conflict of interest
The authors have no disclosures or conflicts of interest to report.
Author information
Authors and Affiliations
Corresponding author
Additional information
P. V. Damasco and J. N. Ramos contributed equally for the first authorship in this manuscript.
Rights and permissions
About this article
Cite this article
Damasco, P.V., Ramos, J.N., Correal, J.C.D. et al. Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals. Infection 42, 835–842 (2014). https://doi.org/10.1007/s15010-014-0640-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-014-0640-2